发酵漆树提取物对健康韩国成人肝功能参数的影响:一项双盲随机对照试验
该研究为随机双盲安慰剂对照试验,纳入79名健康韩国成人,试验组39人每日服用两粒发酵漆树提取物胶囊(主要成分:非瑟酮129 mg和黄颜木素59 mg),对照组40人每日服用两粒安慰剂(主要成分:乳糖627.0 mg),持续12周。结果显示,两组间肝病相关参数和血脂谱的变化值均无显著差异。
要点
- 发酵漆树提取物组与安慰剂组肝病相关参数变化值无显著差异。
- 两组间血清血脂谱变化值亦无显著差异。
- 试验组每日摄入非瑟酮129 mg和黄颜木素59 mg,持续12周。
核心结论
- 本研究未证实发酵漆树提取物对肝功能参数和血脂谱具有显著影响。
研究设计与样本
- 随机双盲安慰剂对照试验,纳入79名健康韩国成人,试验组39人、对照组40人,干预12周。
主要发现
- 两组间肝病相关参数的变化值比较无显著差异。
- 两组间血清血脂谱的变化值比较无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fermented Rhus verniciflua Stokes extract (FRVE) reported an anti-hepatic lipidemic property mediated by the upregulation of AMP-activated protein kinase (AMPK) in cell and animal models. However, it remains unclear whether there is an effect of FRVE on liver disease-related parameters and serum lipid levels in humans. We investigated the effects of FRVE intake for 12 weeks on liver disease-related parameters and serum lipid profiles in Korean adults. METHODS: A randomized, double-blind, placebo-controlled study was conducted among 79 subjects. An aqueous extract of fermented Rhus verniciflua Stokes that was filtered and fermented was prepared. For 12 weeks, the test group (n = 39) consumed two capsules of FRVE (main components: fustin 129 mg and fisetin 59 mg) once daily. The control group (n = 40) consumed two placebo pills (main component: lactose 627.0 mg) once daily. A 1:1 randomization of control and test was performed using computer-generated randomization. Both before and after FRVE intake, anthropometric parameters, liver function-related parameters, and clinical laboratory parameters were measured. The effects between the test and control groups were compared using the Mann-Whitney U test and independent t-test, and the difference between baseline and follow-up values was compared using Wilcoxon rank-sum test and paired t-test. RESULTS: There was no significant difference when comparing the change values of liver disease-related parameters and serum lipid profiles in between groups. CONCLUSIONS: In our study, we did not confirm the significance in liver function parameters and serum lipid profiles. TRIAL REGISTRATION: The study protocol was registered in the Clinical Research Information Service (CRIS: https://cris.nih.go.kr/cris/index.jsp ) under number KCT0005687. Registered on 2 December 2020.
引用
- Kwak JH, Lee HJ, Jeong ST, et al. Effect of fermented Rhus verniciflua stokes extract on liver function parameters in healthy Korean adults: a double-blind randomized controlled trial. Trials. 2021. PMID: 34809689. doi:10.1186/s13063-021-05656-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。